The Asia Pacific newborn screening market is expected to grow rapidly in the coming years due to various factors, such as increasing awareness about the benefits of early detection of genetic disorders and metabolic diseases, rising prevalence of these disorders, and increasing government initiatives to improve healthcare infrastructure. Additionally, the growing focus of key market players on expanding their presence in the region through strategic collaborations, partnerships, and acquisitions is also expected to fuel market growth. However, the high cost of screening tests and inadequate healthcare facilities in certain countries may hinder market growth. Overall, the Asia Pacific newborn screening market is poised for significant growth in the coming years, driven by increasing demand for early detection and treatment of genetic disorders and metabolic diseases in infants.
Asia Pacific Newborn Screening Market
The is estimated to be valued at US$ 308.9 million in 2022 and is expected to exhibit a CAGR of 12.9% during the forecast period (2022-2030).
Prominent Companies in the Asia Pacific Newborn Screening Industry:
Medtronic plc: Medtronic plc is a multinational medical technology company that was founded in 1949. The company is headquartered in Dublin, Ireland, and operates in over 160 countries worldwide. Medtronic offers a range of products and services in the healthcare sector, including devices for newborn screening. In 2021, Medtronic announced the launch of a new product called the Early Access Program for Congenital Hypothyroidism, which is designed to improve the early detection of the condition in newborns.
1. Medtronic plc:
Agilent Technologies: Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2020, Agilent announced the launch of the Agilent SureScan Dx Microarray Scanner, which is designed to improve the accuracy and efficiency of newborn screening tests.
2. Agilent Technologies:
Waters Technologies Corporation: Waters Technologies Corporation is a global leader in analytical science technologies. The company was founded in 1958 and is headquartered in Milford, Massachusetts. Waters offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2021, Waters announced the launch of a new product called the MassTrak Neonatal Kit, which is designed to improve the accuracy and speed of newborn screening tests.
3. Waters Technologies Corporation:
AB SCIEX: AB SCIEX is a global leader in life science research and analytical technologies. The company was founded in 1970 and is headquartered in Framingham, Massachusetts. AB SCIEX offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2020, AB SCIEX announced the launch of a new product called the Triple Quad 6500+ LC-MS/MS System, which is designed to improve the sensitivity and speed of newborn screening tests.
4. AB SCIEX:
Bio-Rad Laboratories: Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics. The company was founded in 1952 and is headquartered in Hercules, California. Bio-Rad offers a range of products and services in the healthcare sector, including equipment and software for newborn screening. In 2021, Bio-Rad announced the launch of a new product called the Neonatal Bilirubin Total Assay, which is designed to improve the accuracy and efficiency of newborn screening tests.